{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:30:44Z","timestamp":1782891044867,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T00:00:00Z","timestamp":1592956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T00:00:00Z","timestamp":1592956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31530023"],"award-info":[{"award-number":["31530023"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Science and Technology Planning Project of Guangzhou","award":["201704020212"],"award-info":[{"award-number":["201704020212"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s12325-020-01413-y","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T14:03:20Z","timestamp":1593007400000},"page":"3551-3561","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Allisartan Isoproxil Improves Endothelial Function and Vascular Damage in Patients with Essential Hypertension: A Single-Center, Open-Label, Randomized Controlled Trial"],"prefix":"10.1007","volume":"37","author":[{"given":"Gaoxing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqiang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,24]]},"reference":[{"issue":"17","key":"1413_CR1","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1016\/j.jacc.2017.09.001","volume":"70","author":"KN Hong","year":"2017","unstructured":"Hong KN, Fuster V, Rosenson RS, Rosendorff C, Bhatt DL. How low to go with glucose, cholesterol, and blood pressure in primary prevention of CVD. J Am Coll Cardiol. 2017;70(17):2171\u201385.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1413_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1161\/01.HYP.25.2.155","volume":"25","author":"RW Alexander","year":"1995","unstructured":"Alexander RW. Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension. 1995;25(2):155\u201361.","journal-title":"Hypertension"},{"issue":"Suppl 3","key":"1413_CR3","doi-asserted-by":"publisher","first-page":"S224","DOI":"10.1097\/01.ASN.0000032544.37147.AE","volume":"13","author":"G Deferrari","year":"2002","unstructured":"Deferrari G, Ravera M, Deferrari L, Vettoretti S, Ratto E, Parodi D. Renal and cardiovascular protection in type 2 diabetes mellitus: angiotensin II receptor blockers. J Am Soc Nephrol. 2002;13(Suppl 3):S224\u2013S22929.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"1413_CR4","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.amjcard.2004.02.050","volume":"93","author":"KK Koh","year":"2004","unstructured":"Koh KK, Han SH, Chung WJ, et al. Comparison of effects of losartan, irbesartan, and candesartan on flow-mediated brachial artery dilation and on inflammatory and thrombolytic markers in patients with systemic hypertension. Am J Cardiol. 2004;93(11):1432\u20135 (A10).","journal-title":"Am J Cardiol."},{"issue":"5","key":"1413_CR5","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1751-7176.2009.00108.x","volume":"11","author":"P Perrone-Filardi","year":"2009","unstructured":"Perrone-Filardi P, Corrado L, Brevetti G, et al. Effects of AT1 receptor antagonism with candesartan on endothelial function in patients with hypertension and coronary artery disease. J Clin Hypertens (Greenwich). 2009;11(5):260\u20135.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"1","key":"1413_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ijcard.2008.11.017","volume":"140","author":"KK Koh","year":"2010","unstructured":"Koh KK, Quon MJ, Han SH, et al. Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs. Int J Cardiol. 2010;140(1):73\u201381.","journal-title":"Int J Cardiol"},{"issue":"3","key":"1413_CR7","doi-asserted-by":"publisher","first-page":"e90217","DOI":"10.1371\/journal.pone.0090217","volume":"9","author":"S Li","year":"2014","unstructured":"Li S, Wu Y, Yu G, Xia Q, Xu Y. Angiotensin II receptor blockers improve peripheral endothelial function: a meta-analysis of randomized controlled trials. PLoS ONE. 2014;9(3):e90217.","journal-title":"PLoS ONE"},{"issue":"5","key":"1413_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1524-6175.2001.01136.x","volume":"3","author":"S Oparil","year":"2001","unstructured":"Oparil S, Williams D, Chrysant SG, Marbury TC, Neutel J. Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension. J Clin Hypertens (Greenwich). 2001;3(5):283\u201391.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"2","key":"1413_CR9","doi-asserted-by":"publisher","first-page":"e0117560","DOI":"10.1371\/journal.pone.0117560","volume":"10","author":"Y Li","year":"2015","unstructured":"Li Y, Li XH, Huang ZJ, et al. A randomized, double blind, placebo-controlled, multicenter phase II trial of allisartan isoproxil in essential hypertensive population at low-medium risk. PLoS ONE. 2015;10(2):e0117560.","journal-title":"PLoS ONE"},{"issue":"12","key":"1413_CR10","doi-asserted-by":"publisher","first-page":"e14907","DOI":"10.1097\/MD.0000000000014907","volume":"98","author":"JQ Zhang","year":"2019","unstructured":"Zhang JQ, Yang GH, Zhou X, et al. Effects of allisartan isoproxil on blood pressure and target organ injury in patients with mild to moderate essential hypertension. Medicine (Baltimore). 2019;98(12):e14907.","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"1413_CR11","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/S0149-2918(04)80049-3","volume":"26","author":"G Derosa","year":"2004","unstructured":"Derosa G, Cicero AF, Bertone G, et al. Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized double-blind study. Clin Ther. 2004;26(8):1228\u2013366.","journal-title":"Clin Ther"},{"issue":"30","key":"1413_CR12","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1093\/eurheartj\/ehz350","volume":"40","author":"DHJ Thijssen","year":"2019","unstructured":"Thijssen DHJ, Bruno RM, van Mil A, et al. Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans. Eur Heart J. 2019;40(30):2534\u201347.","journal-title":"Eur Heart J"},{"issue":"8","key":"1413_CR13","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S0895-7061(03)00918-X","volume":"16","author":"M Munakata","year":"2003","unstructured":"Munakata M. Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients. Am J Hypertens. 2003;16(8):653\u20137.","journal-title":"Am J Hypertens"},{"issue":"5","key":"1413_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/jhh.2008.137","volume":"23","author":"JM Wang","year":"2009","unstructured":"Wang JM, Su C, Wang Y, et al. Elevated circulating endothelial microparticles and brachial-ankle pulse wave velocity in well-controlled hypertensive patients. J Hum Hypertens. 2009;23(5):307\u201315.","journal-title":"J Hum Hypertens"},{"issue":"9","key":"1413_CR15","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.amjhyper.2007.04.005","volume":"20","author":"J Wang","year":"2007","unstructured":"Wang J, Huang Y, Wang Y, et al. Increased circulating CD31+\/CD42\u2212 microparticles are associated with impaired systemic artery elasticity in healthy subjects. Am J Hypertens. 2007;20(9):957\u201364.","journal-title":"Am J Hypertens"},{"issue":"3","key":"1413_CR16","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.ijcard.2012.03.090","volume":"167","author":"F Cheng","year":"2013","unstructured":"Cheng F, Wang Y, Li J, et al. Berberine improves endothelial function by reducing endothelial microparticles-mediated oxidative stress in humans. Int J Cardiol. 2013;167(3):936\u201342.","journal-title":"Int J Cardiol"},{"issue":"2","key":"1413_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.atherosclerosis.2014.03.019","volume":"234","author":"A Schiro","year":"2014","unstructured":"Schiro A, Wilkinson FL, Weston R, Smyth JV, Serracino-Inglott F, Alexander MY. Endothelial microparticles as conveyors of information in atherosclerotic disease. Atherosclerosis. 2014;234(2):295\u2013302.","journal-title":"Atherosclerosis"},{"issue":"4","key":"1413_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nrendo.2015.6","volume":"11","author":"CA Romero","year":"2015","unstructured":"Romero CA, Orias M, Weir MR. Novel RAAS agonists and antagonists: clinical applications and controversies. Nat Rev Endocrinol. 2015;11(4):242\u201352.","journal-title":"Nat Rev Endocrinol."},{"key":"1413_CR19","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1097\/HJH.0000000000000447","volume":"33","author":"C Thomopoulos","year":"2015","unstructured":"Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure-lowering on outcome incidence in hypertension:5. Head-to-head comparisons of various classes of antihypertensive drugs\u2014overview and meta-analyses. J Hypertens. 2015;33:1321\u201341.","journal-title":"J Hypertens."},{"issue":"11","key":"1413_CR20","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1097\/HJH.0000000000001547","volume":"35","author":"C Thomopoulos","year":"2017","unstructured":"Thomopoulos C, Parati G, Zanchetti A. Effects of blood-pressure-lowering treatment on outcome incidence. 12. Effects in individuals with high-normal and normal blood pressure: overview and meta-analyses of randomized trials. J Hypertens. 2017;35(11):2150\u201360.","journal-title":"J Hypertens."},{"issue":"3","key":"1413_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/aps.2009.11","volume":"30","author":"MY Wu","year":"2009","unstructured":"Wu MY, Ma XJ, Yang C, et al. Effects of allisartan, a new AT(1) receptor blocker, on blood pressure and end-organ damage in hypertensive animals. Acta Pharmacol Sin. 2009;30(3):307\u201313.","journal-title":"Acta Pharmacol Sin"},{"issue":"6423","key":"1413_CR22","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/362801a0","volume":"362","author":"R Ross","year":"1993","unstructured":"Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1990s;362(6423):801\u20139.","journal-title":"Nature"},{"issue":"2","key":"1413_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R. Atherosclerosis\u2014an inflammatory disease. N Engl J Med. 1999;340(2):115\u201326.","journal-title":"N Engl J Med"},{"issue":"8","key":"1413_CR24","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1902\/jop.2017.160447","volume":"88","author":"QB Zhou","year":"2017","unstructured":"Zhou QB, Xia WH, Ren J, et al. Effect of intensive periodontal therapy on blood pressure and endothelial microparticles in patients with prehypertension and periodontitis: a randomized controlled trial. J Periodontol. 2017;88(8):711\u201322.","journal-title":"J Periodontol"},{"issue":"5","key":"1413_CR25","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1161\/01.HYP.37.5.1236","volume":"37","author":"S Laurent","year":"2001","unstructured":"Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37(5):1236\u201341.","journal-title":"Hypertension"},{"issue":"1","key":"1413_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1161\/01.HYP.0000224283.76347.8c","volume":"48","author":"AI Tropeano","year":"2006","unstructured":"Tropeano AI, Boutouyrie P, Pannier B, et al. Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives. Hypertension. 2006;48(1):80\u20136.","journal-title":"Hypertension"},{"issue":"1","key":"1413_CR27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1161\/01.HYP.0000165686.50890.c3","volume":"46","author":"JN Cohn","year":"2005","unstructured":"Cohn JN, Duprez DA, Grandits GA. Arterial elasticity as part of a comprehensive assessment of cardiovascular risk and drug treatment. Hypertension. 2005;46(1):217\u201320.","journal-title":"Hypertension"},{"issue":"3","key":"1413_CR28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/FJC.0000000000000503","volume":"70","author":"M Jain","year":"2017","unstructured":"Jain M, Bhosale V, Tripathi D, et al. Antihypertensive drugs aliskiren, nebivolol, and olmesartan reduce hypertension by reducing endothelial microparticles and regulating angiogenesis. J Cardiovasc Pharmacol. 2017;70(3):176\u201383.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"1413_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11239-005-0343-8","volume":"18","author":"S Nomura","year":"2004","unstructured":"Nomura S, Shouzu A, Omoto S, Nishikawa M, Fukuhara S, Iwasaka T. Losartan and simvastatin inhibit platelet activation in hypertensive patients. J Thromb Thrombolysis. 2004;18(3):177\u201385.","journal-title":"J Thromb Thrombolysis"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01413-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-020-01413-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01413-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T01:08:05Z","timestamp":1624496885000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-020-01413-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,24]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1413"],"URL":"https:\/\/doi.org\/10.1007\/s12325-020-01413-y","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,24]]},"assertion":[{"value":"26 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}